SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$0.93
+0.11 (+13.15%)
As of Feb 8, 2:23 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +248.3% upside
Low Target $1.82
Average Target $3.24
High Target $4.40
Current Price $0.93
Current
$0.93
Target
$3.24
$1.82 $3.24 avg $4.40
Scenario Analysis
Bear Case
$1.82
95.6%
Low target
Base Case
$3.24
+248.3%
Avg target
Bull Case
$4.40
+373.0%
High target
Risk/Reward
3.9x
Highly favorable
Price in Context
52-Week High
$2.64
-64.8% from high
52-Week Low
$2.02
+-53.9% from low
Target vs 52W High
$3.24
+22.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%